Little Evidence Supports Opioid Use for Chronic Pain
|
By HospiMedica International staff writers Posted on 27 Jan 2015 |
|
A new study reveals that there is paltry evidence for the long-term safety and efficacy of opioids in the treatment of chronic pain.
Researchers at the Oregon Health & Science University (OHSU; Portland, USA) and the University of Washington (Seattle, USA) searched MEDLINE, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, PsycINFO, and other sources for randomized trials and observational studies that evaluated the effectiveness and harms of opioid therapy in adults with chronic pain who were prescribed long-term (over three months) therapy.
The results showed that no study of opioid therapy evaluated long-term outcomes related to pain, function, quality of life, opioid abuse, or addiction. Conversely, observational studies suggested that opioid therapy for chronic pain is in fact associated with increased risk for overdose, opioid abuse, fractures, myocardial infarction (MI), and markers of sexual dysfunction, although there are few studies for each of these outcomes; for some harms, higher doses were associated with increased risk. The study was published on January 13, 2015, in Annals of Internal Medicine.
“The lack of scientific evidence on effectiveness and harms of long-term opioid therapy for chronic pain is clear and is in striking contrast to its widespread use for this condition and the large increase in prescription opioid-related overdoses,” concluded lead author Roger Chou, MD, of OHSU, and colleagues. “Evidence is insufficient to determine the effectiveness of long-term opioid therapy for improving chronic pain and function. Most randomized, controlled trials of opioids for chronic pain were shorter than 6 weeks, and nearly all ran for no longer than 16 weeks.”
Prescriptions of opioid medications for chronic pain have increased dramatically, a trend that has been accompanied by greatly increased levels of opioid overdose, abuse, addiction, and diversion. When compared with placebo, opioid therapy has been found to be associated with alleviation of pain in the short term, but most opioid trials do not extend beyond six weeks and are of limited relevance to long-term opioid use.
Related Links:
Oregon Health & Science University
University of Washington
Researchers at the Oregon Health & Science University (OHSU; Portland, USA) and the University of Washington (Seattle, USA) searched MEDLINE, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, PsycINFO, and other sources for randomized trials and observational studies that evaluated the effectiveness and harms of opioid therapy in adults with chronic pain who were prescribed long-term (over three months) therapy.
The results showed that no study of opioid therapy evaluated long-term outcomes related to pain, function, quality of life, opioid abuse, or addiction. Conversely, observational studies suggested that opioid therapy for chronic pain is in fact associated with increased risk for overdose, opioid abuse, fractures, myocardial infarction (MI), and markers of sexual dysfunction, although there are few studies for each of these outcomes; for some harms, higher doses were associated with increased risk. The study was published on January 13, 2015, in Annals of Internal Medicine.
“The lack of scientific evidence on effectiveness and harms of long-term opioid therapy for chronic pain is clear and is in striking contrast to its widespread use for this condition and the large increase in prescription opioid-related overdoses,” concluded lead author Roger Chou, MD, of OHSU, and colleagues. “Evidence is insufficient to determine the effectiveness of long-term opioid therapy for improving chronic pain and function. Most randomized, controlled trials of opioids for chronic pain were shorter than 6 weeks, and nearly all ran for no longer than 16 weeks.”
Prescriptions of opioid medications for chronic pain have increased dramatically, a trend that has been accompanied by greatly increased levels of opioid overdose, abuse, addiction, and diversion. When compared with placebo, opioid therapy has been found to be associated with alleviation of pain in the short term, but most opioid trials do not extend beyond six weeks and are of limited relevance to long-term opioid use.
Related Links:
Oregon Health & Science University
University of Washington
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Medical Adhesive
MED 5570U
Digital Radiography System (Ceiling Free)
Digix CF Series
Latest Critical Care News
- Anatomical Guidance System Improves Trauma Ultrasound Acquisition by Novice Users
- AI-Enhanced Handheld Ultrasound Improves Carotid Plaque Detection
- Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible
- New Sensor Could Bring Contactless Vital Sign Monitoring to Hospital Bedsides
- Diamond-Based Magnetometers Could Enable New Approaches to Heart Monitoring
- Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries
- Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease
- FDA Clears Multi-Device ECG Analysis Software for Extended Monitoring
- Multimodal AI Improves Treatment Response Prediction in Lung Cancer
- New Approach Helps Identify Materials for More Reliable Wearable Electronics
- Scotland Adopts Respiratory Infection Control Guidance Informed by Aerosol Research
- Hospital Safety Program Linked to 65% Reduction in MRSA Bloodstream Infections
- Wearable Microneedle Device Aims to Enable Remotely Managed Pain Relief
- Octopus-Inspired Patch Improves Adhesion for Transdermal Drug Delivery
- Multimodal AI System Tracks Early Warning Signs of Mental Health Crisis
- Self-Folding Paper Sensor Conforms to Body Without Straps or Adhesives
Channels
Artificial Intelligence
view channel
AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment
Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more
AI-Powered ECG Model Gains FDA Authorization for Emergency Cardiac Assessment
Powerful Medical’s PMcardio Queen of Hearts (ACS AI ECG Model) has received U.S. Food and Drug Administration (FDA) De Novo authorization, announced on September 15, 2026. The model is designed to identify... Read more
Surgical Techniques
view channel
Handheld Device Improves Targeted Cell Collection for Early Ovarian Cancer Assessment
High-grade serous ovarian cancer is the most common form of ovarian cancer, and many cases are thought to originate in the fallopian tubes. Because precursor lesions can be microscopic, they are difficult... Read more
Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses
Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more
FDA Approves First Sirolimus Drug-Eluting Balloon for Coronary In-Stent Restenosis
Coronary in-stent restenosis (ISR) accounts for about 10% of the nearly one million percutaneous coronary interventions performed annually in the United States. Treating recurrent narrowing without another... Read more
Patient Care
view channel
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read more
Virtual Reality Helps Claustrophobic Patients Complete Cardiac PET/CT Scans
Anxiety and claustrophobia—intense fear of confined spaces—often prevent patients from completing cardiac positron emission tomography/computed tomography (PET/CT). Aborted scans delay diagnosis, consume... Read more
Medical Imaging
view channel
New MRI Approach Captures Rapidly Decaying Tissue Signals
MRI measures signals generated as excited proton spins return toward equilibrium. However, some tissue signals decay so rapidly that conventional systems can miss them during the brief interval after excitation,... Read more
AI Tool Integrates MRI and Ultrasound to Detect Endometriosis
Endometriosis is a chronic condition in which tissue similar to the uterine lining grows outside the uterus, causing pain, heavy bleeding, and infertility. Diagnosis often depends on surgical visualization,... Read more
Health IT
view channel
New Tablet Platform Extends Stroke Neurorehabilitation Beyond the Clinic
Continuity and intensity of neurorehabilitation after stroke are critical for functional recovery, but access to ongoing therapy at home often remains limited. Hospitals and outpatient programs therefore... Read more
Smartphone App Improves Blood Pressure Control in Hypertension
Hypertension, or high blood pressure, is a major modifiable driver of cardiovascular, renal, and cerebrovascular morbidity. Despite effective therapies, many adults fail to achieve control, leading to... Read more
Point of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read more
Business
view channel
Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Robotic Single-Port System Gains CE Mark for Transvaginal Gynecologic Procedures
Intuitive (Sunnyvale, CA, USA) announced that it has received CE mark approval for use of the da Vinci SP Single Port surgical system in transvaginal gynecologic procedures, marking the first such indication... Read more
